Journal of the National Comprehensive Cancer Network 2020

3 papers
In 2020, the Journal of the National Comprehensive Cancer Network (JNCCN) published research focused on clinical outcomes, risk assessment, and treatment efficacy across various malignancies. One area of study involved the development of screening tools to identify older adults with cancer at risk for poor outcomes, highlighting a focus on geriatric oncology. Other research evaluated surgical interventions, specifically analyzing postoperative complications following primary cytoreduction in patients with advanced epithelial ovarian cancer. Additionally, the journal featured findings on the survival benefits of adjuvant chemotherapy for locoregionally advanced rectal cancer using data from the Veterans Health Administration. This work emphasizes the use of large-scale clinical data to refine treatment protocols. Prolific authors contributing to the journal during this period included Areej El-Jawahri, Jennifer S. Temel, and Daniel E. Lage. The 2020 edition reflects an emphasis on evidence-based guidelines and the optimization of care for diverse patient populations through risk stratification and retrospective analysis of treatment outcomes.

Top Research Directions

The 4 research directions with Journal of the National Comprehensive Cancer Network 2020 papers, ranked by paper count, next to 2019. Share is the fraction of the edition’s papers in the direction.

#Direction20202019Share 2020Share 20192019 rank
1False Discovery Rate Control for High Dimensional Data1033.3%0.0%—
2Patient Reported Outcome Measures for Evaluating Treatment Success1033.3%0.0%—
3Proportional Hazards Modeling for Survival Analysis1033.3%0.0%—
4The Aging Prevalence Paradox in Global Health Burden1033.3%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Journal of the National Comprehensive Cancer Network 2020 papers: a paper credits every institution named in its affiliations, once. 3 institutions share 1 credited papers.

#InstitutionPapersShare20192019 rank
1Harvard Medical School 1100.0%0—
2Massachusetts General Hospital 1100.0%0—
3University of Maryland School of Medicine 1100.0%0—

Download all institutions as CSV

About this data

Papers. Journal of the National Comprehensive Cancer Network 2020 lists 3 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2019 use shares, since the edition went from 2 to 3 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 3 papers (33.3%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of the National Comprehensive Cancer Network 2020”, https://lacuna.tiptreesystems.com/venue/journal-of-the-national-comprehensive-cancer-network/2020.

Impactful Papers

Papers from Journal of the National Comprehensive Cancer Network 2020 that shaped research clusters.

Influential

Papers

Title
CLO20-069: Evaluation and analysis of postoperative complications after primary cytoreduction for 47 cases of advanced epithelial ovarian cancer at stage IIIc and IV RUNNING HEAD (maximum 40 character
Screening Tool Identifies Older Adults With Cancer at Risk for Poor Outcomes
Survival Advantage With Adjuvant Chemotherapy for Locoregionally Advanced Rectal Cancer: A Veterans Health Administration Analysis